Evidence map›Paper›PMID 10023662›Full record

ArticleOncogene1999

p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry.

S Levenberg, A Yarden, Z Kam, B Geiger

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Pterygium surgery using the principle of contact inhibition: results of 13 years' experience.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2017
    Article
  11. Article
  12. SIRT1 controls cell proliferation by regulating contact inhibition.Biochemical and biophysical research communications · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

S LevenbergDepartment of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel.
A Yarden
Z Kam
B Geiger

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study the direct involvement of cadherins in adhesion-mediated growth inhibition was investigated. It is shown here that overexpression of N-cadherin in CHO cells significantly suppresses their growth rate. Interaction of these cells and two additional fibroblastic lines with synthetic beads coated with N-cadherin ligands (recombinant N-cadherin ectodomain or specific antibodies) leads to growth arrest at the G1 phase of the cell cycle. The cadherin-reactive beads inhibit the entry into S phase and the reduction in the levels of cyclin-dependent kinase (cdk) inhibitors p21 and p27, following serum-stimulation of starved cells. In exponentially growing cells these beads induce G1 arrest accompanied by elevation in p27 only. We propose that cadherin-mediated signaling is involved in contact inhibition of growth by inducing cell cycle arrest at the G1 phase and elevation of p27 levels.

Indexed as

Cell CommunicationCell CycleCell Cycle ProteinsTumor Suppressor ProteinsAnimalsCadherinsCell CountCHO CellsCricetinaeCyclin-Dependent Kinase Inhibitor p27DNA, ComplementaryG1 PhaseLigandsMicrotubule-Associated ProteinsPeptide FragmentsS PhaseCadherinsCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p27DNA, ComplementaryLigandsMicrotubule-Associated ProteinsPeptide FragmentsTumor Suppressor Proteins

Identifiers

PMID10023662

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.